SHEMESH SHAY (Chief Development Officer) purchased 0.0% of their position (300.00 shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $2.1K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/18/2022ACC: 0001104659-22-120080
Officer· Chief Development Officer
Since Feb 2022
+300.00
Net shares
Net buyer
$2.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
300.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150.00
Price / share
$7.10
Trade value
$1.06K
% of position
0.0%
11/16/2022
1.25M→1.25M
Common Stock
Direct
Shares
+150.00
Price / share
$7.20
Trade value
$1.08K
% of position
0.0%
11/17/2022
1.25M→1.25M
Total
Net shares
+300.00
Net value
$2.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/16/2022 | P · Purchase | +150.00 | $7.10 | $1.06K | 0.0% | 1.25M | 1.25M |
| Common Stock Direct | 11/17/2022 | P · Purchase | +150.00 | $7.20 | $1.08K | 0.0% | 1.25M | 1.25M |
| Total | +300.00 | $2.15K | ||||||
Derivative Transactions0
No derivative transactions reported